Form4insider filings, from the source

SEC Form 4 · accession 0001225208-16-028753

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael P. Phalen
Officer — EVP & President, MedSurg
Period of report
Feb 27, 2016
Accepted (ET)
Mar 1, 2016 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 27, 2016M6,370$0.00A97,498D
Common StockF2Feb 27, 2016F3,001$17.21D94,497D
Common StockF1,F2Feb 28, 2016M8,381$0.00A102,878D
Common StockF1,F2Feb 28, 2016M5,413$0.00A108,291D
Common StockF2Feb 28, 2016F6,498$17.21D101,793D
Common StockF2Feb 29, 2016S1,819$17.1918D99,974D
Common StockF4holding———2,429IBy 401(k)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF6,F1,F5—Feb 27, 2016M6,370D——Common Stock6,37030,990D
Deferred Stock UnitsF6,F1,F7—Feb 28, 2016M5,413D——Common Stock5,41325,577D
Deferred Stock UnitsF6,F1,F8—Feb 28, 2016M8,381D——Common Stock8,38117,196D

Explanation of responses